These last two groups differed significantly from the cancer-free survivors with regard to their serum CRP levels (p = 0.003), frequency of large tumors at the time of diagnosis (p < 0.001), and frequency of Fuhrman G3-G4 nuclear grading (p = 0.001). This evidence concerns the gene CRP and cancer.